Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38264
CAS Number:
112665-43-7
Seratrodast
Purity:
≥ 98% (HPLC)
Synonym(s):
(+/-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoicacid
Documents
$153.63 /100MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Seratrodast is a potent compound recognized for its role as a selective leukotriene receptor antagonist, primarily utilized in the management of asthma and allergic rhinitis. This compound is particularly beneficial in reducing inflammation and bronchoconstriction, making it a valuable option for patients seeking relief from respiratory conditions. Its unique structure allows for targeted action, minimizing side effects commonly associated with other treatments. Researchers and healthcare professionals appreciate Seratrodast for its efficacy in improving lung function and enhancing the quality of life for individuals suffering from chronic respiratory issues.

In addition to its therapeutic applications, Seratrodast is also being explored for its potential in various research settings, including studies on inflammation and immune response. Its ability to modulate leukotriene pathways opens avenues for innovative treatments in related fields, such as cardiovascular health and autoimmune disorders. With its favorable safety profile and targeted action, Seratrodast stands out as a promising candidate for both clinical and research applications, offering significant advantages over traditional therapies.

Synonyms
(+/-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoicacid
CAS Number
112665-43-7
Purity
≥ 98% (HPLC)
Molecular Formula
C22H26O4
Molecular Weight
354.45
MDL Number
MFCD00875701
PubChem ID
2449
Melting Point
126 - 130 °C
Appearance
Light yellow to brown powder to crystal
Conditions
Store at < 0 °C
General Information
Synonyms
(+/-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoicacid
CAS Number
112665-43-7
Purity
≥ 98% (HPLC)
Molecular Formula
C22H26O4
Molecular Weight
354.45
MDL Number
MFCD00875701
PubChem ID
2449
Melting Point
126 - 130 °C
Appearance
Light yellow to brown powder to crystal
Conditions
Store at < 0 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Seratrodast is widely utilized in research focused on

  • Asthma Treatment: This compound is primarily used as a therapeutic agent for managing asthma symptoms by acting as a leukotriene receptor antagonist, helping to reduce inflammation and bronchoconstriction.
  • Allergy Relief: It is effective in alleviating allergic reactions, making it a valuable option in the development of medications aimed at treating allergic rhinitis and other allergy-related conditions.
  • Cardiovascular Health: Research indicates that Seratrodast may play a role in cardiovascular health by improving endothelial function and reducing vascular inflammation, which can benefit patients with heart disease.
  • Research in Inflammatory Diseases: The compound is being studied for its potential applications in treating various inflammatory diseases, providing insights into new therapeutic pathways for conditions like rheumatoid arthritis.
  • Drug Development: Its unique mechanism of action makes Seratrodast a candidate for further drug development, particularly in creating combination therapies that enhance efficacy while minimizing side effects.

Citations